R&D
Arrowhead’s RNA Drug Cut Triglycerides ~80% and Slashed Pancreatitis in Phase 3
Plozasiran — an injectable that silences a gene controlling fat metabolism — sharply lowered triglycerides and reduced dangerous pancreatitis attacks in severe hypertriglyceridemia.